VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ADPT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ADPTAdaptive Biotechnologies Corporation
$20.82$3.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksADPTQuarterly Financials

Adaptive Biotechnologies Corporation (ADPT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Adaptive Biotechnologies Corporation (ADPT) quarterly income statement — complete revenue, gross profit & net income history

ADPT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue70.87M71.68M93.97M58.88M52.44M47.46M46.44M43.19M41.87M45.78M37.92M48.93M37.65M55.2M47.83M43.66M38.62M37.93M39.47M38.51M
Revenue Growth %35.14%51.04%102.38%36.33%25.24%3.66%22.46%-11.72%11.23%-17.05%-20.72%12.06%-2.52%45.53%21.19%13.39%0.46%25.66%50.07%83.46%
Cost of Goods Sold18.71M18.22M18.16M18M16.98M18.05M16.67M19.32M18.05M19.62M19.35M17.91M18.68M16.59M14.91M13.22M13.19M14.36M14.19M10.77M
COGS % of Revenue26.4%25.42%19.32%30.57%32.38%38.02%35.89%44.73%43.11%42.84%51.02%36.61%49.62%30.05%31.17%30.28%34.16%37.85%35.95%27.96%
Gross Profit52.17M53.46M75.82M40.88M35.46M29.41M29.77M23.87M23.82M26.17M18.57M31.02M18.97M38.61M32.92M30.44M25.43M23.57M25.28M27.74M
Gross Margin %73.6%74.58%80.68%69.43%67.62%61.98%64.11%55.27%56.89%57.16%48.98%63.39%50.38%69.95%68.83%69.72%65.84%62.15%64.05%72.04%
Gross Profit Growth %47.1%81.74%154.69%71.24%48.87%12.4%60.28%-23.03%25.6%-32.22%-43.59%1.9%-25.41%63.78%30.24%9.73%-10.63%-1.62%24.85%72.56%
Operating Expenses71.37M66.23M65.53M65.92M65.07M63.25M62.4M71.19M72.58M97.24M69.53M78.83M76.16M77.8M78.35M82.94M88.5M85.17M81.6M77.5M
OpEx % of Revenue100.7%92.4%69.73%111.95%124.07%133.28%134.38%164.83%173.34%212.38%183.36%161.13%202.3%140.94%163.82%189.97%229.14%224.55%206.76%201.29%
Selling, General & Admin47.33M44.04M41.43M41.36M40.45M39.63M37.81M38.21M41.92M42.63M40.57M46.17M43.14M46.14M42.27M45.48M50.24M50.04M45.1M39.28M
SG&A % of Revenue66.78%61.44%44.09%70.24%77.12%83.51%81.42%88.47%100.1%93.12%106.99%94.38%114.59%83.6%88.37%104.17%130.08%131.93%114.28%102.02%
Research & Development23.62M21.76M23.67M24.13M24.2M23.19M24.16M25.35M30.25M28.75M28.53M32.24M32.6M31.22M35.66M37.04M37.84M34.7M36.07M37.8M
R&D % of Revenue33.33%30.36%25.19%40.99%46.15%48.87%52.04%58.7%72.23%62.79%75.25%65.89%86.6%56.56%74.55%84.83%97.98%91.48%91.4%98.17%
Other Operating Expenses419K429K428K423K419K428K428K1000K423K1000K428K423K419K429K428K423K419K429K428K423K
Operating Income-19.21M-12.77M10.29M-25.04M-29.6M-33.84M-32.63M-47.32M-48.76M-71.07M-50.96M-47.82M-57.19M-39.19M-45.43M-52.5M-63.07M-61.6M-56.33M-49.77M
Operating Margin %-27.1%-17.82%10.95%-42.52%-56.45%-71.3%-70.27%-109.56%-116.45%-155.22%-134.38%-97.74%-151.92%-70.99%-94.98%-120.25%-163.3%-162.39%-142.71%-129.24%
Operating Income Growth %35.12%62.25%131.53%47.09%39.29%52.39%35.96%1.05%14.74%-81.36%-12.16%8.92%9.31%36.38%19.34%-5.5%-52.78%-39.23%-52.03%-34.83%
EBITDA-19.21M-8.58M14.7M-20.53M-26.45M-29.39M-28.04M-42.31M-43.55M-65.68M-45.19M-40.34M-51.77M-33.9M-40.05M-47.31M-58.01M-56.75M-52.8M-46.86M
EBITDA Margin %-27.1%-11.97%15.64%-34.87%-50.44%-61.92%-60.39%-97.97%-104%-143.45%-119.18%-82.44%-137.51%-61.42%-83.73%-108.35%-150.21%-149.61%-133.78%-121.7%
EBITDA Growth %27.39%70.81%152.41%51.47%39.26%55.25%37.95%-4.91%15.88%-93.73%-12.85%14.74%10.76%40.26%24.15%-0.95%-50.25%-29.53%-51.26%-34.23%
D&A (Non-Cash Add-back)04.2M4.41M4.5M3.15M4.45M4.59M5M5.21M5.39M5.76M7.48M5.42M5.29M5.38M5.2M5.06M4.85M3.53M2.9M
EBIT-19.21M-10.63M12.52M-22.64M-32.76M-30.77M-29.16M-43.55M-44.54M-66.45M-46.67M-44.21M-54.17M-36.58M-44.67M-52.08M-62.8M-61.6M-56M-49.77M
Net Interest Income0-806K-745K-557K-226K120K535K1.07M1.23M1.6M630K7K-507K-983K112K418K271K239K327K464K
Interest Income02.15M2.23M2.39M2.68M3.07M3.47M3.77M4.22M4.61M4.28M3.61M3.02M2.6M765K418K271K239K327K464K
Interest Expense-2.89M2.95M2.97M2.95M2.9M2.95M2.94M2.7M2.99M3.01M3.65M3.6M3.53M3.58M653K00000
Other Income/Expense-827K-806K-744K-557K-248K120K561K1.07M1.23M1.6M630K7K-507K-983K112K418K271K239K327K464K
Pretax Income-20.03M-13.58M9.55M-25.59M-29.85M-33.72M-32.07M-46.25M-47.53M-69.47M-50.33M-47.81M-57.7M-40.17M-45.32M-52.08M-62.8M-61.36M-56M-49.3M
Pretax Margin %-28.27%-18.94%10.16%-43.47%-56.92%-71.04%-69.07%-107.08%-113.52%-151.73%-132.72%-97.72%-153.27%-72.77%-94.75%-119.29%-162.6%-161.76%-141.89%-128.04%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-20.03M-13.58M9.55M-25.61M-29.85M-33.69M-32.07M-46.22M-47.51M-69.44M-50.3M-47.81M-57.7M-40.13M-45.28M-52.05M-62.8M-61.34M-55.9M-49.3M
Net Margin %-28.27%-18.94%10.16%-43.5%-56.92%-70.99%-69.07%-107.02%-113.45%-151.67%-132.65%-97.72%-153.26%-72.7%-94.67%-119.21%-162.6%-161.71%-141.64%-128.04%
Net Income Growth %32.89%59.7%129.77%44.58%37.16%51.48%36.24%3.32%17.66%-73.05%-11.08%8.14%8.12%34.58%19%-5.57%-54.51%-37.62%-52.25%-47.01%
Net Income (Continuing)-20.03M-13.58M9.55M-25.59M-29.85M-33.72M-32.07M-46.25M-47.53M-69.47M-50.33M-47.81M-57.7M-40.17M-45.32M-52.08M-62.8M-61.36M-56M-49.3M
Discontinued Operations00000000000000000000
Minority Interest7.9M6.21M-182K-181K-202K-224K-199K-173K-147K-121K-95K-69K-68K-67K-26K12K50K110K34K129K
EPS (Diluted)-0.13-0.090.06-0.17-0.20-0.23-0.22-0.31-0.33-0.48-0.35-0.33-0.40-0.17-0.32-0.36-0.44-0.43-0.40-0.35
EPS Growth %35%60.87%126.59%45.16%39.39%52.08%37.14%6.06%17.5%-182.35%-9.38%8.33%9.09%60.47%20%-2.86%-51.72%-30.3%-48.15%-34.62%
EPS (Basic)-0.13-0.090.06-0.17-0.20-0.23-0.22-0.31-0.33-0.48-0.35-0.33-0.40-0.17-0.32-0.37-0.44-0.44-0.40-0.35
Diluted Shares Outstanding155.52M153.13M163.16M152.08M149.19M147.1M147.52M147.41M145.79M144.9M144.7M144.4M143.51M143.05M142.93M142.36M141.7M141.23M140.83M140.36M
Basic Shares Outstanding155.52M153.13M152.43M152.08M149.19M147.1M147.52M147.41M145.79M144.9M144.7M144.4M143.51M143.05M142.93M140.66M141.7M140.21M140.83M140.36M
Dividend Payout Ratio--------------------